neonatal%20jaundice
NEONATAL JAUNDICE
Jaundice that appears in a newborn <24 hour old is most likely nonphysiologic and needs further evaluation.
Jaundice typically presents on the 2nd-3rd day of life. It is usually first seen on the face and forehead then progresses caudally to the trunk and extremities.
Visible jaundice in the feet may be an indication to check bilirubin level.
Visual estimation of bilirubin level is often inaccurate and unreliable.
Danger signs in a newborn infant with jaundice includes changes in brainstem evoked auditory potentials, changes in muscle tone, seizures and altered cry characteristics.
The presence of any of the danger signs require prompt attention to prevent kernicterus.
  1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 weeks or more of gestation. Pediatr. 2004 Jul;114(1):297-316. http://pediatrics.aappublications.org/content/114/1/297.full.pdf. PMID: 15231951
  2. Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004 Jul;114(1):e130-316. PMID: 15231986
  3. Riskin A, Tamir A, Kugelman A, et al. Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia?. J Pediatr. 2008 Jun;152(6):782-787. doi: 10.1016/j.jpeds.2007.11.003. PMID: 18492516
  4. Moerschel SK, Cianciaruso LB, Tracy LR. A practical approach to neonatal jaundice. Am Fam Physician. 2008 May;77(9):1255-1262. PMID: 18540490
  5. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  6. Ministry of Health Malaysia. Clinical practice guidelines: management of jaundice in healthy term newborns. http://www.moh.gov.my/. Feb 2003
  7. Agency for Healthcare Research and Quality. Management of neonatal hyperbilirubinemia (summary). http://www.ahrq.gov/clinic/epcsums/neonatalsum.pdf. 2002
  8. Hansen TWR. Jaundice, neonatal. www.emedicine.medscape.com. Oct 2007
  9. National Institute for Health and Clinical Excellence. Clinical guidance 98 neonatal jaundice: full guideline. NICE website. https://www.nice.org.uk/guidance/cg98/resources/guidance-neonatal-jaundice-pdf. May 2010.
  10. Ministry of Health Malaysia. Clinical practice guidelines: management of neonatal jaundice. 2nd ed. Malaysia Health Technology Assessment Section (MaHTAS): Ministry of Health Malaysia; 2014 Dec. http://www.moh.gov.my/penerbitan/CPG/CPG%20Management%20of%20Neonatal%20Jaundice%20(Second%20Edition).pdf.
  11. Wong RJ, Bhutani VK. Treatment of unconjugated hyperbilirubinemia in term and late preterm infants. UptoDate website. http://www.uptodate.com/contents/treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants. Sep 2015.
  12. Bhutani VK, Wong RJ. Hyperbilirubinemia in the premature infant (less than 35 weeks gestation). UptoDate website. http://www.uptodate.com/contents/hyperbilirubinemia-in-the-premature-infant-less-than-35-weeks-gestation. Oct 2015.
  13. Ministry of Health Malaysia. Clinical practice guidelines: management of neonatal jaundice (second edition). Ministry of Health Malaysia Web Site. http://www.moh.gov.my/penerbitan/CPG/CPG%20Management%20of%20Neonatal%20Jaundice%20(Second%20Edition).pdf. 2015.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
Roshini Claire Anthony, 3 days ago

The presence of pulmonary arterial hypertension (PAH) in individuals with systemic sclerosis is associated with an increased mortality risk, a study from Singapore showed.

23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Stephen Padilla, 6 days ago
Brodalumab has exhibited long-term efficacy and consistent safety profile for more than 2 years in the treatment of patients with psoriasis, results of the phase III AMAGINE-2 trial show.